Genmab A (GMAB) Assets (2019 - 2026)
Genmab A's (GMAB) quarterly Assets came in at $12.4 billion in Q1 2026, up 87.91% YoY from $6.6 billion in Q1 2025, and down 3.86% on a QoQ basis from $12.9 billion in Q4 2025.
Genmab A (GMAB) Assets (2019 - 2026) Analysis & Trends
Genmab A (GMAB) has 6 years of Assets data on file, last reported at $12.4 billion in Q1 2026.
- Quarterly Assets rose 87.91% year-over-year to $12.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 billion (up 87.91% YoY) and the FY2025 annual result came in at $12.9 billion, up 100.7% from the prior year.
- Assets eased to $12.4 billion in Q1 2026, from $12.9 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $12.9 billion in Q4 2025 to a low of $5.2 billion in Q4 2023.
- A 4-year average of $8.1 billion and a median of $6.6 billion in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets increased 22.59% — and 2025, when it surged 100.7%.
- Tracing GMAB's Assets over 4 years: stood at $5.2 billion in 2023, then increased by 22.59% to $6.4 billion in 2024, then jumped by 100.7% to $12.9 billion in 2025, then slipped by 3.86% to $12.4 billion in 2026.
- The last three Assets figures came in at $12.4 billion (Q1 2026), $12.9 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | 12.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Bn |
| Mar 31, 2026 | 12.38 Bn |
| Dec 31, 2025 | 12.87 Bn |
| Sep 30, 2025 | 7.02 Bn |
| Jun 30, 2025 | 6.46 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.41 Bn |
| Dec 31, 2023 | 5.23 Bn |
| Sep 30, 2020 | 21,522,000.00 Bn |
| Dec 31, 2019 | 15,035.00 |
| Sep 30, 2019 | 13,330,000.00 Bn |